Open-label add-on treatment trial of minocycline in fragile X syndrome

BACKGROUND: Fragile X syndrome (FXS) is a disorder characterized by a variety of disabilities, including cognitive deficits, attention-deficit/hyperactivity disorder, autism, and other socio-emotional problems. It is hypothesized that the absence of the fragile X mental retardation protein (FMRP) le...

Descripción completa

Detalles Bibliográficos
Autores principales: Paribello, Carlo, Tao, Leeping, Folino, Anthony, Berry-Kravis, Elizabeth, Tranfaglia, Michael, Ethell, Iryna M, Ethell, Douglas W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958860/
https://www.ncbi.nlm.nih.gov/pubmed/20937127
http://dx.doi.org/10.1186/1471-2377-10-91

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958860/
https://www.ncbi.nlm.nih.gov/pubmed/20937127
http://dx.doi.org/10.1186/1471-2377-10-91

Ejemplares similares